全文获取类型
收费全文 | 734878篇 |
免费 | 64911篇 |
国内免费 | 48230篇 |
专业分类
耳鼻咽喉 | 5925篇 |
儿科学 | 8740篇 |
妇产科学 | 10443篇 |
基础医学 | 83318篇 |
口腔科学 | 12382篇 |
临床医学 | 101062篇 |
内科学 | 104579篇 |
皮肤病学 | 7721篇 |
神经病学 | 37722篇 |
特种医学 | 26565篇 |
外国民族医学 | 391篇 |
外科学 | 70300篇 |
综合类 | 126531篇 |
现状与发展 | 153篇 |
一般理论 | 92篇 |
预防医学 | 50482篇 |
眼科学 | 21094篇 |
药学 | 78203篇 |
716篇 | |
中国医学 | 43689篇 |
肿瘤学 | 57911篇 |
出版年
2024年 | 2243篇 |
2023年 | 9877篇 |
2022年 | 25970篇 |
2021年 | 33183篇 |
2020年 | 25556篇 |
2019年 | 21572篇 |
2018年 | 23129篇 |
2017年 | 21659篇 |
2016年 | 20153篇 |
2015年 | 30629篇 |
2014年 | 38656篇 |
2013年 | 35589篇 |
2012年 | 52603篇 |
2011年 | 59510篇 |
2010年 | 39142篇 |
2009年 | 31679篇 |
2008年 | 40388篇 |
2007年 | 40683篇 |
2006年 | 39879篇 |
2005年 | 39210篇 |
2004年 | 25743篇 |
2003年 | 24153篇 |
2002年 | 20428篇 |
2001年 | 18280篇 |
2000年 | 18657篇 |
1999年 | 19514篇 |
1998年 | 12055篇 |
1997年 | 11873篇 |
1996年 | 9195篇 |
1995年 | 8659篇 |
1994年 | 7340篇 |
1993年 | 4829篇 |
1992年 | 6296篇 |
1991年 | 5391篇 |
1990年 | 4514篇 |
1989年 | 3925篇 |
1988年 | 3346篇 |
1987年 | 2978篇 |
1986年 | 2431篇 |
1985年 | 1853篇 |
1984年 | 1112篇 |
1983年 | 804篇 |
1982年 | 447篇 |
1981年 | 452篇 |
1980年 | 363篇 |
1979年 | 457篇 |
1978年 | 213篇 |
1977年 | 164篇 |
1974年 | 158篇 |
1973年 | 132篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
Edward J. Holland Walter O. Whitley Kenneth Sall Stephen S. Lane Aparna Raychaudhuri Steven Y. Zhang 《Current medical research and opinion》2016,32(10):1759-1765
Objective: Report efficacy findings from three clinical trials (one phase 2 and two phase 3 [OPUS-1, OPUS-2]) of lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease (DED).Research design and methods: Three 84-day, randomized, double-masked, placebo-controlled trials. Adults (≥18 years) with DED were randomized (1:1) to lifitegrast 5.0% or matching placebo. Changes from baseline to day 84 in signs and symptoms of DED were analyzed.Main outcome measures: Phase 2, pre-specified endpoint: inferior corneal staining score (ICSS; 0–4); OPUS-1, coprimary endpoints: ICSS and visual-related function subscale (0–4 scale); OPUS-2, coprimary endpoints: ICSS and eye dryness score (EDS, VAS; 0–100).Results: Fifty-eight participants were randomized to lifitegrast 5.0% and 58 to placebo in the phase 2 trial; 293 to lifitegrast and 295 to placebo in OPUS-1; 358 to lifitegrast and 360 to placebo in OPUS-2. In participants with mild-to-moderate baseline DED symptomatology, lifitegrast improved ICSS versus placebo in the phase 2 study (treatment effect, 0.35; 95% CI, 0.05–0.65; p?=?0.0209) and OPUS-1 (effect, 0.24; 95% CI, 0.10–0.38; p?=?0.0007). Among more symptomatic participants (baseline EDS ≥40, recent artificial tear use), lifitegrast improved EDS versus placebo in a post hoc analysis of OPUS-1 (effect, 13.34; 95% CI, 2.35–24.33; nominal p?=?0.0178) and in OPUS-2 (effect, 12.61; 95% CI, 8.51–16.70; p?<?0.0001).Limitations: Trials were conducted over 12 weeks; efficacy beyond this period was not assessed.Conclusions: Across three trials, lifitegrast improved ICSS in participants with mild-to-moderate baseline symptomatology in two studies, and EDS in participants with moderate-to-severe baseline symptomatology in two studies. Based on the overall findings from these trials, lifitegrast shows promise as a new treatment option for signs and symptoms of DED. 相似文献
46.
47.
48.
目的探讨指压天枢穴加腹部按摩联合番泻叶在静脉肾盂造影患者中的应用效果。方法选取我院2018年12月至2019年8月期间行静脉肾盂造影的120例患者,随机分为两组各60例。对照组给予番泻叶,观察组给予天枢穴指压加腹部按摩联合番泻叶,比较两组的肠道清洁力度和不良反应情况。结果治疗后,观察组的肠道清洁力度明显高于对照组(P <0.05);观察组的不良反应发生率为6.67%,明显低于对照组的23.33%(P <0.05)。结论静脉肾盂造影患者采用指压天枢穴加腹部按摩联合番泻叶的效果较好,可提高肠道清洁力度,降低不良反应发生率。 相似文献
49.
Anatoly E Martynyuk Ling-Sha Ju Timothy E Morey Jia-Qiang Zhang 《World Journal of Psychiatry》2020,10(5):81-94
The progress of modern medicine would be impossible without the use of general anesthetics (GAs). Despite advancements in refining anesthesia approaches, the effects of GAs are not fully reversible upon GA withdrawal. Neurocognitive deficiencies attributed to GA exposure may persist in neonates or endure for weeks to years in the elderly. Human studies on the mechanisms of the long-term adverse effects of GAs are needed to improve the safety of general anesthesia but they are hampered not only by ethical limitations specific to human research, but also by a lack of specific biological markers that can be used in human studies to safely and objectively study such effects. The latter can primarily be attributed to an insufficient understanding of the full range of the biological effects induced by GAs and the molecular mechanisms mediating such effects even in rodents, which are far more extensively studied than any other species. Our most recent experimental findings in rodents suggest that GAs may adversely affect many more people than is currently anticipated. Specifically, we have shown that anesthesia with the commonly used GA sevoflurane induces in exposed animals not only neuroendocrine abnormalities (somatic effects), but also epigenetic reprogramming of germ cells (germ cell effects). The latter may pass the neurobehavioral effects of parental sevoflurane exposure to the offspring, who may be affected even at levels of anesthesia that are not harmful to the exposed parents. The large number of patients who require general anesthesia, the even larger number of their future unexposed offspring whose health may be affected, and a growing number of neurodevelopmental disorders of unknown etiology underscore the translational importance of investigating the intergenerational effects of GAs. In this mini review, we discuss emerging experimental findings on neuroendocrine, epigenetic, and intergenerational effects of GAs. 相似文献
50.
李宏军 《中华泌尿外科杂志》2020,(4):247-250
手术治疗精索静脉曲张在改善精液质量、提高配偶自然怀孕率和缓解局部疼痛症状中的作用已为多数医生所认同。随着手术方式的改进,越来越多的精索静脉曲张患者接受手术治疗,然而,临床对手术后患者的管理还重视不够。本文系统介绍了对精索静脉曲张手术后患者的疗效判断和后续治疗选择,包括观察随诊、非手术治疗方法和再手术。 相似文献